0001140361-14-001183.txt : 20140107
0001140361-14-001183.hdr.sgml : 20140107
20140107173011
ACCESSION NUMBER: 0001140361-14-001183
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140107
FILED AS OF DATE: 20140107
DATE AS OF CHANGE: 20140107
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NATIONAL RESEARCH CORP
CENTRAL INDEX KEY: 0000070487
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 470634000
STATE OF INCORPORATION: WI
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1245 Q STREET
CITY: LINCOLN
STATE: NE
ZIP: 68508
BUSINESS PHONE: 4024752525
MAIL ADDRESS:
STREET 1: 1245 Q STREET
CITY: LINCOLN
STATE: NE
ZIP: 68508
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Karas Kevin R
CENTRAL INDEX KEY: 0001522907
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35929
FILM NUMBER: 14514373
MAIL ADDRESS:
STREET 1: C/O NATIONAL RESEARCH CORPORATION
STREET 2: 1245 Q STREET
CITY: LINCOLN
STATE: NE
ZIP: 68508
4
1
doc1.xml
FORM 4
X0306
4
2014-01-07
0
0000070487
NATIONAL RESEARCH CORP
NRCIA/B
0001522907
Karas Kevin R
C/O NATIONAL RESEARCH CORPORATION
1245 Q STREET
LINCOLN
NE
68508
0
1
0
0
SVP Finance, CFO, Treas & Secy
Class A Common Stock
20892
D
Class B Common Stock
3482
D
Employee Stock Option (right to buy)
18.8
2014-01-07
4
A
0
5334
0
A
2024-01-07
Class A Common Stock
5334
5334
D
Employee Stock Option (right to buy)
34.15
2014-01-07
4
A
0
489
0
A
2024-01-07
Class B Common Stock
489
489
D
Employee Stock Option (right to buy)
10.75
2022-01-05
Class A Common Stock
26403
26403
D
Employee Stock Option (right to buy)
14.5
2023-01-07
Class A Common Stock
20088
20088
D
Employee Stock Option (right to buy)
21.5
2022-01-05
Class B Common Stock
4400
4400
D
Employee Stock Option (right to buy)
27.13
2023-01-07
Class B Common Stock
3348
3348
D
On May 22, 2013, the Issuer completed a recapitalization pursuant to which it, among other things, issued a stock dividend of three shares of class A common stock for each share of then-existing common stock and reclassified each share of its then-existing common stock as one-half of one share of class B common stock. All fractional shares of class B common stock were cashed-out in the recapitalization. In connection with the recapitalization, the exercise prices of outstanding options were equitably adjusted to prevent the dilution or enlargement of the benefits intended to be provided.
This option becomes fully exercisable on January 7, 2019.
This option becomes fully exercisable on January 5, 2017.
This option becomes fully exercisable on January 7, 2018.
/s/ Russell E. Ryba, Attorney-in-Fact for Kevin R. Karas
2014-01-07